XCENE RESEARCH

Xcene Research is an African based Contract Research Organisation finding Innovative Global Health Solutions for Today and the Future through Clinical Research.

[XCENE RESEARCH @xceneresearch]

Breakthroughs in healthcare are powered by collaboration, and every new partnership brings us closer to better patient outcomes across Africa.

We are pleased to welcome Helix Biogen Institute as an official partner of the Sickle Cell Disease African Scientific Symposium (#SCDASS2026).

Together, we are championing scientific excellence, strengthening research collaboration, and advancing drug discovery and development to accelerate innovative solutions for Sickle Cell Disease in Africa.

Venue: Marriott Hotel, Ikeja
Date: July 30–31, 2026

Scan the QR code to register and join researchers, clinicians, innovators, and policymakers shaping the future of Sickle Cell Disease care across the continent.

#SCDASS2026 #SickleCellDisease #HelixBiogenInstitute

[XCENE RESEARCH @xceneresearch]

Innovation thrives when visionary organizations come together to solve Africa's most pressing healthcare challenges.

Xcene Research is proud to welcome The Insilico Lab as an official partner of the Sickle Cell Disease African Scientific Symposium (#SCDASS2026).

This partnership shows our shared commitment to advancing scientific innovation, accelerating drug discovery, and supporting collaborative research that will shape the future of #SickleCellDisease treatment and care across Africa.

Together, we are driving the conversations, partnerships, and breakthroughs that turn promising research into impactful solutions.

Marriott Hotel, Ikeja
July 30–31, 2026

Scan the QR code to register and join the movement advancing drug development for Sickle Cell Disease in Africa.

#Xceneresearch #SCDASS2026 #DrugDiscovery #AfricanResearch

[XCENE RESEARCH @xceneresearch]

Progress in Sickle Cell Disease care and research is made possible when organizations come together with a shared vision for impact.

We are delighted to welcome SickleVive Care & Empowerment Foundation as an official partner of the Sickle Cell Disease African Scientific Symposium (#SCDASS2026).

This collaboration reflects our shared commitment to amplifying the voices of the sickle cell community, fostering innovation, and supporting efforts that drive meaningful progress in Sickle Cell Disease care and research across the continent.

Venue: Marriott Hotel, Ikeja
Date: July 30–31, 2026

Scan the QR code to register and be part of the conversation shaping the future of Sickle Cell Disease in Africa.

#XceneResearch #SCDASS2026 #SickleCellDisease

[XCENE RESEARCH @xceneresearch]

At Xcene Research, International Clinical Trials Day 2026 was more than a celebration; it was an opportunity to raise awareness, spark important conversations, and spotlight Africa's growing role in global clinical research.

We hosted an awareness program featuring Principal Investigators, Clinical Research Associates (CRAs), and other stakeholders who shared insights on the importance of clinical trials, research participation, ethics, innovation, and the future of healthcare in Africa.

We are also excited to see the conversation amplified through national media coverage by BusinessDay.

You can read the full story using the link below:

https://t.co/3K6Xixq2xs

As Africa continues to emerge as a critical frontier for medical innovation, collaboration and awareness remain essential in building trust, increasing participation, and strengthening research capacity across the continent.

A big thank you to everyone who contributed to making the event a success.

#InternationalClinicalTrialsDay #ICTD2026 #ClinicalResearch

[XCENE RESEARCH @xceneresearch]

Partnerships like this are critical to accelerating progress in Sickle Cell Disease research across Africa!

We are excited to welcome the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) as an official partner for the Sickle Cell Disease African Scientific Symposium (#SCDASS2026).

This partnership represents a shared commitment to improving outcomes for patients and supporting groundbreaking research across the continent.

Marriott Hotel, Ikeja
July 30–31, 2026

Scan the QR code to join the conversation.

#Xceneresearch #SickleCellDisease #DrugDevelopment

[XCENE RESEARCH @xceneresearch]

Strong clinical research ecosystems are not built by isolated sites. They are built through collaboration, standardization, visibility, and shared excellence.

Across Sub-Saharan Africa, many capable research sites remain outside the global clinical trial ecosystem—not because of limited expertise, but because they lack access to the networks, partnerships, and visibility that drive multinational studies.

This is why the Xcene Research Site Alliance Network (XRSAN) was created.

XRSAN is designed to connect high-performing clinical research sites, strengthen operational readiness, and position sites for greater participation in globally compliant clinical trials.

Because the future of clinical research in Africa will not be built by individual institutions working alone, it will be built through connected, research-ready ecosystems.

Swipe through to explore why networks like XRSAN matter for the future of clinical research.

#XRSAN #XceneResearch #ClinicalTrialsAfrica

[XCENE RESEARCH @xceneresearch]

Most Clinical Trial Recruitment Strategies do not fail because of a lack of patients. They fail because they are built on the wrong assumptions.

Africa has more than 3,000 ethnic groups, languages, and cultural systems across the continent. Patient engagement is shaped by factors that go far beyond clinical definitions of disease. Health decisions are influenced by community structures, trust in healthcare systems, cultural beliefs, and lived experiences that differ widely from one region to another.

In today’s article, Xcene Research explores effective strategies for developing robust recruitment models for African clinical trials.

Click the link below to learn more.

https://t.co/XyjX2Ha8gA

#Clinicaltrials #Xceneresearch

[XCENE RESEARCH @xceneresearch]

Call for Abstracts Still Open - #SCDASS 2026!

Are you working on groundbreaking research in #SickleCellDisease?

This is your opportunity to play a pivotal role in shaping the future of drug development in Africa.

The Sickle Cell Disease African Scientific Symposium (#SCDASS) 2026 is now accepting abstract submissions for its upcoming scientific session themed:

“Accelerating Drug Development for Sickle Cell Disease in Africa.”

If your work focuses on drug discovery, translational science, or innovative therapeutic approaches in SCD, we encourage you to submit.

Travel Grant Available for Selected Abstracts

Venue: Marriott Hotel, Ikeja
Date: July 30th – 31st, 2026
Time: 8:00 AM – 5:00 PM

Submit your abstract here:
https://t.co/OgZUTxLxFP

Join Xcene Research and members of the Scientific Committee, Olawale Salami, Biobele Brown, and Fidele Ntie-Kang (PhD, Habilitation, MRSC) as we drive innovation and accelerate progress in #SickleCellDisease across Africa.

#SCDASS2026 #XceneResearch #CallForAbstracts

[XCENE RESEARCH @xceneresearch]

We’re proud to be an Event Partner at the Africa Health Business (AHB) Symposium 2026.

As conversations around healthcare financing and sustainability continue to shape Africa’s future, platforms like AHB are critical in driving the right partnerships, policies, and innovations forward.

At Xcene Research, we believe clinical research is not just about discovery, it is a powerful engine for strengthening health systems, advancing access to new therapies, and unlocking economic growth across the continent.
That’s why we’re excited to contribute to this important conversation.

Our CEO, Adebukunola Telufusi, will be speaking at the symposium sharing insights on how clinical trials can accelerate impact, sustainability, and long-term value for Africa’s healthcare ecosystem.

If you’ll be in Nairobi, we invite you to join our session and engage with us.

Date: 21–23 April 2026
Venue: Ole Sereni Hotel, Nairobi, Kenya
Register here: https://t.co/OHvXGmtQ8p

Let’s shape the future of healthcare in Africa together.

#XceneResearch #AHBSymposium #ClinicalTrials #AfricaHealth

[XCENE RESEARCH @xceneresearch]

Our CEO, Adebukunola Telufusi, recently met with the Honorable Minister for Health and Social Welfare, Dr. Iziaq Adekunle Salako, to reflect on Xcene Research’s decade-long impact as a Clinical Research Organization (CRO) and to outline our strategic roadmap for the next 10 years.

The discussion highlighted our ongoing expansion in clinical trials and laboratory research, the development of a robust framework for research and development, our expanding footprint across Africa, and the Xcene Research Site Alliance Network (#XRSAN).

According to our CEO, Adebukunola Telufusi: Our goal for the next decade is to ensure Africa plays a central role in scientific data and solutions, in partnership with the Ministry of Health and global stakeholders. Self-reliance in Nigeria and Africa, strengthened by strategic collaboration with international partners, is essential to robustly elevate the local research ecosystem and drive sustainable innovation. This principle underpins our decade-long impact, our expansion in clinical trials and laboratory research, and our commitment to a resilient, Africa-centered research landscape through the Xcene Research Site Alliance Network (XRSAN).

We remain dedicated to close collaboration with the Federal Ministry of Health and Social Welfare Nigeria, as well as other stakeholders, to cultivate a resilient research environment that delivers life-saving innovations for all Africans.

#Clinicaltrials #Xceneresearch #clinicalresearch

[XCENE RESEARCH @xceneresearch]

Empowering women in healthcare drives discoveries that transform lives and shape the future. When we enable women to lead, innovate, and thrive in science, research, and healthcare, everyone gains.

Today, we celebrate the brilliant women at Xcene Research and across the global scientific community whose expertise, vision, and dedication remind us that giving to women is giving to progress.

Happy International Women’s Day

#gaintogive #IWD2026 #xceneresearch #womeninhealthcare

[XCENE RESEARCH @xceneresearch]

#Oncology burden in Nigeria and across Africa remains substantial, with high incidence and mortality from common cancers and challenges such as late-stage presentation and limited access to affordable therapies. Breast cancer is the most frequently diagnosed cancer among women in many African settings, while cervical cancer continues to be a leading cause of cancer-related mortality due to screening gaps. Treatment availability varies by country and region, with persistent gaps in access to targeted therapies, radiotherapy, and timely diagnostic services in many markets. Africa hosts a growing ecosystem of cancer research networks and trials, yet there remains a need for expanded capacity, data sharing, and multi-site trial infrastructure to accelerate discovery and bring therapies to patients faster.

@xceneresearch recently engaged with the National Institute of Cancer Research and Treatment (@NicratGov) to explore strategic partnerships that advance research, prevention, early detection, treatment access, and #clinicaltrials for Nigerian and African cancer patients. This engagement aligns with NICRaT’s mandate and strengthens collaboration to accelerate cancer care across the region.

Our Collaboration Vision centers on a joint commitment where Xcene Research and Xcene Laboratories and Diagnostics will collaborate across research, early detection screening, treatment access, and clinical trials. There is a regional emphasis on cancers with the highest burden in Africa and Nigeria, including breast, ovarian, liver, cervical, prostate, and pediatric oncology. We also aim to enhance transparency and visibility of research and trials through the Xcene Research site alliance network, integrated with NICRaT’s existing alliance network to attract more research opportunities.

Strategic priorities include a focus on oncology areas such as breast cancer, ovarian cancer, cervical cancer, prostate cancer, and pediatric oncology, alongside research and trial acceleration, streamlined pathways to initiate and conduct clinical trials with patient-centric design and robust data sharing. We are committed to expanding access to affordable, community-based early detection and screening programs to improve early diagnosis and outcomes, facilitating equitable access to innovative therapies and standards of care across Nigeria and neighboring regions, and strengthening local research capabilities, clinical trial infrastructure, and workforce development.

Our alignment with NICRaT’s mandate centers on supporting cancer research, prevention, treatment, and control across Nigeria and Africa, while leveraging Xcene’s alliance network to attract additional high-quality research projects. This collaboration embodies a shared value proposition: a patient-centric research ecosystem that prioritizes timely access to cutting-edge therapies and evidence-based care, with a commitment to a scientific culture that increases access and saves lives.

During the meeting, our CEO, Adebukunola Telufusi, stated that “The best time to create these solutions is now.” This sentiment reflects our determination to act boldly and decisively to improve cancer care. We are proud to align with NICRaT’s mandate to enhance visibility and value in cancer research, prevention, and treatment because progress in cancer care cannot occur in silos. Together, we are nurturing a scientific culture that increases access and saves lives.

Looking ahead, we plan to finalize a joint collaboration framework that outlines governance, data sharing, co-branding, and joint communications, and to develop a co-branded project pipeline highlighting priority studies in breast, ovarian, cervical, prostate, and pediatric oncology. We will also create a transparent, patient-centric protocol for trial recruitment, ethical oversight, and informed consent tailored to local contexts, and schedule follow-up stakeholder meetings to confirm milestones, resource commitments, and KPI targets, including trial initiation timelines, screening program roll-out, and capacity-building activities. Importantly, all treatment initiatives emphasized here are anchored in improving access to cancer care for patients in Nigeria and across Africa.

#Xceneresearch #Clinicaltrials #Clinicalresearch

[XCENE RESEARCH @xceneresearch]

XCENE RESEARCH VIRTUAL CAREER FAIR 2025
Explore. Connect. Grow.

At Xcene Research, we are committed to building the next generation of #ClinicalResearch Professionals, shaping and impacting healthcare outcomes across Sub-Saharan Africa.

Are you passionate about advancing healthcare and innovation across Africa?

Join us for a virtual career fair webinar where you’ll:

- Learn about exciting career opportunities within Xcene Research
- Access guidance on how to thrive in the Clinical Research industry
- Explore roles that align with your skills and aspirations

Venue: Virtual (Zoom)
Date: Thursday, November 6th, 2025
Time: 6:00 PM (WAT)

🔗 Register here:
https://t.co/61Lczz908g

Be a part of the team driving and accelerating medical innovations across Africa.

#Xceneresearch #Clinicalresearch #Xceneresearchcareers

[XCENE RESEARCH @xceneresearch]

Africa holds 16% of the world’s population, yet contributes less than 3% of global clinical trials. This gap limits access to innovative therapies, delays medical breakthroughs, and leaves much of Africa’s unique health data untapped.

At @xceneresearch, we’re bridging that divide as your Indigenous #CRO Partner with Local Expertise and Global Impact across Sub-Saharan Africa.

As an indigenous Contract Research Organization (CRO), we understand the local context, regulatory environments, and community dynamics that shape successful studies in Africa.
Our mission is simple: to accelerate access to life-saving treatment across Sub-Saharan Africa by combining local expertise with global standards of quality, ethics, and compliance.

From bioanalysis to site management, data monitoring, and patient engagement, we’re building the infrastructure and capacity needed to make Africa a true partner in global research.

#XceneResearch #ClinicalTrials #HealthcareInnovation #CRO

[XCENE RESEARCH @xceneresearch]

Across Africa, the healthcare and laboratory ecosystem continues to face significant challenges, including limited access to advanced diagnostic infrastructure, long sample turnaround times, and dependence on foreign laboratories for complex testing and clinical research support. These gaps often slow down medical innovation, delay patient care, and hinder the continent’s ability to fully contribute to global health advancements.

We are excited to introduce Xcene Laboratories and Diagnostics (XLD), delivering excellence in quality research and diagnostics across Africa.

At XLD we’re bridging global standards with local expertise, offering reliable, high-quality diagnostic and research solutions that empower better healthcare outcomes across the continent.

Join our waiting list and be part of our journey to make world-class laboratory science accessible across Africa.

Scan the QR code or click the link below: https://t.co/ofBVok294z

#XceneLaboratoriesandDiagnostics #XLD #Researchanddiagnostics

[XCENE RESEARCH @xceneresearch]

At ASCAT 2025, Xcene Research was honoured to share its journey in advancing sickle cell disease (SCD) clinical trials across Sub-Saharan Africa.

Our Executive Director, Adebukunola Telufusi, represented by Uchechukwu Nwaoha, a Senior Clinical Trial Associate at Xcene Research, presented on the theme:
Conducting SCD Trials in Sub-Saharan Africa: Milestones, Insights, and Xcene Research's Impact.

With a decade of experience conducting SCD trials in 5 Sub-Saharan African countries alongside global sponsors, we have learned that the true success of a clinical trial extends beyond recruitment and retention.

Our experience has led to important insights such as:

- The value of strengthening industry trial experience at sites
- The role of infrastructure and accredited laboratories in trial quality
- How regulatory pathways and sample logistics shape trial timelines
- The importance of comprehensive patient support systems
- The need for sponsors to adapt protocols to African healthcare realities and nuances

These continue to guide us as we work to bridge gaps, enhance capacity, and deliver impactful research outcomes for communities across Africa.

#SickleCell #ClinicalResearch #ASCAT2025 #XceneResearch

[XCENE RESEARCH @xceneresearch]

Xcene Laboratory and Diagnostics (XLD) is Catalyzing a New Era for African Research and Diagnostics!

Every medical breakthrough, every lifesaving treatment, and every public health victory began with one invisible step: a test. A vial of blood. A strand of DNA. A microscopic sample that tells us what the human eye cannot see.

Today's Blog highlights the remarkable vision of Xcene Laboratory and Diagnostics (XLD) to catalyze innovation, advance research, and improve healthcare delivery across Africa.

Do enjoy the read by visiting the link below:

https://t.co/nVsv9y9XK7

Feel free to leave your thoughts in the comments below.

#XceneLaboratoryandDiagnostics #XceneResearch